Agilent Technologies Inc (NYSE:A) CFO Didier Hirsch sold 5,710 shares of the company’s stock in a transaction dated Thursday, June 1st. The stock was sold at an average price of $60.60, for a total transaction of $346,026.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Agilent Technologies Inc (A) traded down 0.67% on Monday, reaching $60.40. 1,473,282 shares of the company traded hands. The stock has a market capitalization of $19.39 billion, a price-to-earnings ratio of 33.95 and a beta of 1.19. Agilent Technologies Inc has a 1-year low of $41.98 and a 1-year high of $61.15. The stock’s 50-day moving average is $56.47 and its 200-day moving average is $50.92.
Agilent Technologies (NYSE:A) last announced its earnings results on Monday, May 22nd. The medical research company reported $0.58 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.48 by $0.10. Agilent Technologies had a net margin of 10.99% and a return on equity of 15.49%. The business had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the firm posted $0.44 earnings per share. The business’s revenue for the quarter was up 8.1% on a year-over-year basis. Equities research analysts expect that Agilent Technologies Inc will post $2.24 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 26th. Stockholders of record on Monday, July 3rd will be issued a $0.132 dividend. This represents a $0.53 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date is Thursday, June 29th. Agilent Technologies’s payout ratio is presently 37.59%.
TRADEMARK VIOLATION NOTICE: This news story was originally published by sleekmoney and is the property of of sleekmoney. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://sleekmoney.com/agilent-technologies-inc-a-cfo-didier-hirsch-sells-5710-shares-of-stock/1882768.html.
A has been the subject of a number of recent analyst reports. Deutsche Bank AG reaffirmed a “buy” rating and issued a $58.00 price objective (up from $56.00) on shares of Agilent Technologies in a research report on Sunday, April 2nd. Zacks Investment Research raised shares of Agilent Technologies from a “sell” rating to a “hold” rating in a research report on Friday, February 17th. Jefferies Group LLC reissued a “buy” rating and set a $59.00 target price on shares of Agilent Technologies in a research report on Friday, March 17th. Morgan Stanley increased their target price on shares of Agilent Technologies from $65.00 to $70.00 and gave the company an “overweight” rating in a research report on Wednesday, May 24th. Finally, BTIG Research increased their target price on shares of Agilent Technologies from $57.00 to $65.00 and gave the company a “buy” rating in a research report on Wednesday, May 24th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $59.31.
Several hedge funds and other institutional investors have recently bought and sold shares of A. BlackRock Inc. boosted its position in Agilent Technologies by 1,946.9% in the first quarter. BlackRock Inc. now owns 23,119,219 shares of the medical research company’s stock worth $1,222,310,000 after buying an additional 21,989,739 shares during the last quarter. Norges Bank bought a new position in Agilent Technologies during the fourth quarter worth approximately $118,636,000. FMR LLC boosted its position in Agilent Technologies by 11.8% in the fourth quarter. FMR LLC now owns 20,784,414 shares of the medical research company’s stock worth $946,938,000 after buying an additional 2,200,865 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Agilent Technologies by 31.4% in the first quarter. JPMorgan Chase & Co. now owns 8,366,511 shares of the medical research company’s stock worth $442,338,000 after buying an additional 1,999,376 shares during the last quarter. Finally, MARSHALL WACE ASIA Ltd bought a new position in Agilent Technologies during the first quarter worth approximately $58,065,000.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/agilent-technologies-inc-a-cfo-didier-hirsch-sells-5710-shares-of-stock/1882768.html
Receive News & Ratings for Agilent Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.